CBX4 contributes to HIV-1 latency by forming phase-separated nuclear bodies and SUMOylating EZH2.
Saved in:
| Title: | CBX4 contributes to HIV-1 latency by forming phase-separated nuclear bodies and SUMOylating EZH2. |
|---|---|
| Authors: | Wu L; Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China., Pan T; Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.; Center for Infection and Immunity Study, School of Medicine, Sun Yat-sen University, Shenzhen, China., Zhou M; Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China., Chen T; Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China., Wu S; Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China., Lv X; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China., Liu J; Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China., Yu F; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China., Guan Y; Core Laboratory Platform for Medical Science, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China., Liu B; Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China., Zhang W; Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China., Deng X; Center for Infection and Immunity Study, School of Medicine, Sun Yat-sen University, Shenzhen, China., Chen Q; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China., Liang A; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China., Lin Y; Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China., Wang L; Shenzhen Blood Center, Shenzhen, China., Tang X; Department of Infectious Diseases, Guangzhou 8th People's Hospital, Guangzhou, China., Cai W; Department of Infectious Diseases, Guangzhou 8th People's Hospital, Guangzhou, China., Li L; Department of Infectious Diseases, Guangzhou 8th People's Hospital, Guangzhou, China., He X; Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China., Zhang H; Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.; Guangzhou Laboratory, Guangzhou International Bio-Island, Guangzhou, China., Ma X; Institute of Human Virology, Key Laboratory of Tropical Disease Control of Ministry Education, Guangdong Engineering Research Center for Antimicrobial Agent and Immunotechnology, Zhongshan School of Medicine, Sun Yat-sen University, Guangzhou, China.; Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.; Guangzhou Laboratory, Guangzhou International Bio-Island, Guangzhou, China. |
| Source: | EMBO reports [EMBO Rep] 2022 Jul 05; Vol. 23 (7), pp. e53855. Date of Electronic Publication: 2022 Jun 01. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't |
| Journal Info: | Publisher: Nature Publishing Group Country of Publication: England NLM ID: 100963049 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1469-3178 (Electronic) Linking ISSN: 1469221X NLM ISO Abbreviation: EMBO Rep Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
